Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

Privia Health Group, Inc. (PRVA)

Compare
23.25
+0.80
+(3.56%)
As of 1:50:44 PM EDT. Market Open.
Loading Chart for PRVA
  • Previous Close 22.45
  • Open 22.45
  • Bid 23.19 x 100
  • Ask 23.31 x 100
  • Day's Range 22.23 - 23.25
  • 52 Week Range 15.92 - 26.04
  • Volume 492,140
  • Avg. Volume 748,681
  • Market Cap (intraday) 2.802B
  • Beta (5Y Monthly) 0.85
  • PE Ratio (TTM) 211.36
  • EPS (TTM) 0.11
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 29.71

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

www.priviahealth.com

1,140

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PRVA

View More

Performance Overview: PRVA

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PRVA
18.93%
S&P 500 (^GSPC)
4.39%

1-Year Return

PRVA
22.30%
S&P 500 (^GSPC)
7.24%

3-Year Return

PRVA
15.18%
S&P 500 (^GSPC)
23.70%

5-Year Return

PRVA
1.09%
S&P 500 (^GSPC)
127.62%

Compare To: PRVA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PRVA

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    2.71B

  • Enterprise Value

    2.22B

  • Trailing P/E

    204.09

  • Forward P/E

    42.92

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.62

  • Price/Book (mrq)

    4.26

  • Enterprise Value/Revenue

    1.28

  • Enterprise Value/EBITDA

    91.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.83%

  • Return on Assets (ttm)

    0.99%

  • Return on Equity (ttm)

    2.64%

  • Revenue (ttm)

    1.74B

  • Net Income Avi to Common (ttm)

    14.38M

  • Diluted EPS (ttm)

    0.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    491.15M

  • Total Debt/Equity (mrq)

    0.82%

  • Levered Free Cash Flow (ttm)

    104.86M

Research Analysis: PRVA

View More

Company Insights: PRVA

Research Reports: PRVA

View More

People Also Watch